X-155614626-A-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001304990.2(SPRY3):c.-282+1979A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.66 ( 17697 hom., 21440 hem., cov: 22)
Failed GnomAD Quality Control
Consequence
SPRY3
NM_001304990.2 intron
NM_001304990.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.691
Publications
0 publications found
Genes affected
SPRY3 (HGNC:11271): (sprouty RTK signaling antagonist 3) Involved in negative regulation of MAPK cascade. Predicted to be located in membrane. Predicted to be active in cytosol. [provided by Alliance of Genome Resources, Apr 2022]
TMLHE (HGNC:18308): (trimethyllysine hydroxylase, epsilon) This gene encodes the protein trimethyllysine dioxygenase which is the first enzyme in the carnitine biosynthesis pathway. Carnitine play an essential role in the transport of activated fatty acids across the inner mitochondrial membrane. The encoded protein converts trimethyllysine into hydroxytrimethyllysine. A pseudogene of this gene is found on chromosome X. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
TMLHE Gene-Disease associations (from GenCC):
- epsilon-trimethyllysine hydroxylase deficiencyInheritance: Unknown, XL Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia
- autism spectrum disorderInheritance: XL Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001304990.2. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
Frequencies
GnomAD3 genomes AF: 0.661 AC: 72713AN: 110017Hom.: 17695 Cov.: 22 show subpopulations
GnomAD3 genomes
AF:
AC:
72713
AN:
110017
Hom.:
Cov.:
22
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.661 AC: 72752AN: 110071Hom.: 17697 Cov.: 22 AF XY: 0.663 AC XY: 21440AN XY: 32357 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
72752
AN:
110071
Hom.:
Cov.:
22
AF XY:
AC XY:
21440
AN XY:
32357
show subpopulations
African (AFR)
AF:
AC:
13722
AN:
30358
American (AMR)
AF:
AC:
6905
AN:
10408
Ashkenazi Jewish (ASJ)
AF:
AC:
1994
AN:
2615
East Asian (EAS)
AF:
AC:
2495
AN:
3461
South Asian (SAS)
AF:
AC:
1855
AN:
2564
European-Finnish (FIN)
AF:
AC:
4345
AN:
5713
Middle Eastern (MID)
AF:
AC:
168
AN:
211
European-Non Finnish (NFE)
AF:
AC:
39815
AN:
52571
Other (OTH)
AF:
AC:
991
AN:
1495
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
810
1621
2431
3242
4052
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
648
1296
1944
2592
3240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.